Amyloid-related imaging abnormalities (ARIA) in Alzheimer’s disease patients treated with bapineuzumab: A retrospective analysis

Por Sperling, Reisa, Salloway, Stephen, Brooks, David J., Tampieri, Donatella, Barakos, Jerome, Fox, Nick C., Raskind, Murray, Sabbagh, Marwan, Honig, Lawrence S., Porsteinsson, Anton P., Lieberburg, Ivan, Arrighi, H. Michael, Morris, Kristen A., Lu, Yuan, Liu, Enchi, Gregg, Keith M., Brashear, Robert H., Kinney, Gene G., Black, Ronald, Grundman, Michael
Publicado em 2012

Amyloid-β (11)C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials

Por Liu, Enchi, Schmidt, Mark E., Margolin, Richard, Sperling, Reisa, Koeppe, Robert, Mason, Neale S., Klunk, William E., Mathis, Chester A., Salloway, Stephen, Fox, Nick C., Hill, Derek L., Les, Andrea S., Collins, Peter, Gregg, Keith M., Di, Jianing, Lu, Yuan, Tudor, I. Cristina, Wyman, Bradley T., Booth, Kevin, Broome, Stephanie, Yuen, Eric, Grundman, Michael, Brashear, H. Robert
Publicado no Neurology (2015)